SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.625
AS - Asia 14.949
EU - Europa 9.214
SA - Sud America 2.685
AF - Africa 225
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 56.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.015
SG - Singapore 5.937
CN - Cina 4.333
BR - Brasile 2.294
DE - Germania 2.031
UA - Ucraina 1.740
HK - Hong Kong 1.596
IT - Italia 1.416
TR - Turchia 1.229
VN - Vietnam 923
GB - Regno Unito 922
FI - Finlandia 710
RU - Federazione Russa 583
PL - Polonia 482
SE - Svezia 463
MX - Messico 303
FR - Francia 272
ID - Indonesia 257
CA - Canada 241
IN - India 183
AR - Argentina 167
ZA - Sudafrica 123
NL - Olanda 114
BD - Bangladesh 108
JP - Giappone 91
CZ - Repubblica Ceca 90
BE - Belgio 89
EC - Ecuador 77
ES - Italia 77
AT - Austria 69
IQ - Iraq 61
LT - Lituania 51
MA - Marocco 33
PK - Pakistan 33
CO - Colombia 27
PY - Paraguay 27
CL - Cile 26
UZ - Uzbekistan 26
VE - Venezuela 23
PE - Perù 21
AE - Emirati Arabi Uniti 19
IL - Israele 19
AU - Australia 17
KE - Kenya 17
CH - Svizzera 14
DO - Repubblica Dominicana 14
RO - Romania 14
IE - Irlanda 13
IR - Iran 13
JO - Giordania 13
KR - Corea 13
TN - Tunisia 12
AZ - Azerbaigian 11
EG - Egitto 11
SA - Arabia Saudita 11
EU - Europa 10
JM - Giamaica 10
UY - Uruguay 10
BO - Bolivia 9
DZ - Algeria 9
YE - Yemen 9
BG - Bulgaria 8
KZ - Kazakistan 8
TT - Trinidad e Tobago 8
HU - Ungheria 7
LV - Lettonia 7
NP - Nepal 7
PA - Panama 7
MY - Malesia 6
OM - Oman 6
PH - Filippine 6
AL - Albania 5
BB - Barbados 5
BY - Bielorussia 5
CR - Costa Rica 5
HN - Honduras 5
HR - Croazia 5
BH - Bahrain 4
CI - Costa d'Avorio 4
LB - Libano 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SI - Slovenia 4
SN - Senegal 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MK - Macedonia 3
NG - Nigeria 3
PS - Palestinian Territory 3
PT - Portogallo 3
AM - Armenia 2
BW - Botswana 2
DM - Dominica 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
Totale 56.701
Salva come PNG Salva come JPEG
Città #
Singapore 3.349
Fairfield 3.016
Woodbridge 2.968
Ashburn 2.724
Houston 2.035
Jacksonville 1.862
Chandler 1.677
Hong Kong 1.592
Beijing 1.483
Ann Arbor 1.362
Santa Clara 1.345
Seattle 1.176
Wilmington 1.131
Cambridge 976
Izmir 647
Nanjing 593
Dallas 496
Munich 482
Princeton 480
Los Angeles 479
Warsaw 460
New York 428
San Diego 311
Boardman 309
Ho Chi Minh City 293
Ferrara 280
Milan 242
São Paulo 230
Mexico City 212
Shanghai 210
Jakarta 201
Shenyang 189
Hanoi 182
Nanchang 172
Turku 171
Helsinki 151
Dong Ket 132
Hebei 128
Bremen 115
Hefei 114
London 114
Tianjin 114
Addison 113
Chicago 110
Buffalo 108
Changsha 101
Montreal 89
Falls Church 88
Jiaxing 88
Moscow 87
Brussels 86
Dearborn 83
Tokyo 82
Brooklyn 80
Rio de Janeiro 80
Toronto 75
Jinan 73
Zhengzhou 71
Johannesburg 70
Chennai 69
Mountain View 69
Stockholm 66
Denver 64
Phoenix 63
Redwood City 63
San Francisco 60
Falkenstein 59
Orem 58
Norwalk 55
Poplar 52
Brasília 51
Brno 50
Atlanta 49
Rome 49
Belo Horizonte 47
Bologna 47
Frankfurt am Main 47
Nuremberg 47
Kunming 46
San Mateo 46
Manchester 45
Curitiba 44
Boston 42
Guangzhou 41
Haiphong 41
The Dalles 41
Ningbo 40
Lappeenranta 34
Olomouc 34
Orange 34
Biên Hòa 30
Vienna 30
Washington 30
Ankara 29
Columbus 29
Des Moines 29
Hangzhou 29
Quito 29
Verona 28
Auburn Hills 27
Totale 37.958
Salva come PNG Salva come JPEG
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 367
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 261
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 260
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 246
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 238
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 237
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 234
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 232
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 232
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 231
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 230
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 229
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia 227
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 226
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 225
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 225
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 222
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 219
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 219
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 217
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 216
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 216
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 216
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 216
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 214
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 214
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 213
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 212
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 212
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 212
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 207
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 205
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 204
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 203
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 202
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 202
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 194
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 194
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 193
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 193
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 193
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 192
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 192
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 192
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 192
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 192
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 190
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 190
Delirium in acute promyelocytic leukemia patients: Two case reports 190
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 190
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 188
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 188
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 188
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 187
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 186
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 186
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 185
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 185
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 185
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 185
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 184
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 183
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 182
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 180
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 177
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 177
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 177
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 176
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 176
Dendritic cells in acute promyelocytic leukaemia 175
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 173
Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome 173
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 173
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 172
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 171
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 171
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 170
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 169
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 169
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 168
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 168
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 168
Hepatosplenic T-cell lymphoma (HSTCL). 167
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 167
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 166
Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia 166
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 165
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 164
Exercise training and endothelial progenitor cells in haemodialysis patients 164
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 164
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 163
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 162
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 159
Waldenstrom macroglobulinemia 159
Multilineage involvement in the 5q- syndrome: A fluorescent in situ hybridization study on bone marrow smears 158
A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia 158
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 158
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 158
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 157
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 157
Totale 19.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 287.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 34.938
Totale 322.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.619 0 0 0 0 0 620 206 639 109 802 779 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/20259.403 315 200 787 324 1.145 746 242 510 1.537 1.225 1.265 1.107
2025/202614.328 2.382 1.385 2.438 3.786 3.813 524 0 0 0 0 0 0
Totale 57.514